A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE
NCT ID: NCT07125027
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
32 participants
INTERVENTIONAL
2025-08-31
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objectives are to determine whether it is feasible for participants to use each component of the program when delivered online, to assess how acceptable and engaging each component is, and to evaluate the impact on pain, physical function, and daily activity levels. The study intervention will be conducted entirely remotely. Participants will complete online surveys, brief daily check-ins on their phone, and wear a small activity monitor on the hip to measure movement. They will also undergo quantitative sensory testing to evaluate pain sensitivity. At the end of the program, participants will share feedback about their experiences via qualitative interviews.
The findings will help identify which parts of the program provide the greatest benefit, with the ultimate goal of developing a more targeted and effective digital program for people with this condition.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to 1) develop a multicomponent intervention that integrates Mindfulness-Oriented Recovery Enhancement and physical activity for patients with LR, 2) assess the feasibility and acceptability of this multicomponent intervention, and 3) evaluate preliminary efficacy of the intervention via self-report measures of pain, disability, kinesiophobia, and other psychosocial factors related to chronic pain. In addition, this study will use quantitative sensory testing (i.e., pressure and heat pain thresholds) as an objective measure of pain.
The multicomponent intervention will be developed (AIM 1) using qualitative data from focus groups of LR patients and semi-structured interviews from a multidisciplinary sample of physicians who treat LR. This data will be analyzed using a thematic approach to assess barriers and facilitators to participation, patients' perspectives on non-pharmacologic interventions, and physicians' views of medically necessary considerations. Qualitative findings will be presented to a team of expert mindfulness instructors to support program design. In a single arm trial designed to assess feasibility, acceptability, and preliminary efficacy of the intervention (AIMS 2 and 3), we will administer the multicomponent program developed in Aim 1. Data will be collected from participants at three time points: baseline, midpoint, post-intervention, 3-month follow-up. In addition, ratings of pain intensity will be captured daily via ecologic momentary assessment.
During the intervention period, participants will be asked to attend virtual classes once a week. Between weekly sessions, participants will also be asked to track their home practice, daily levels of pain, and any adverse events via a daily survey. At the end of the study, participants will be asked to participate in a semi-structured exit interview which will inquire about their experience in the intervention.
This study seeks to shift the current research paradigm by being the first to develop and test a novel non-invasive, non-pharmacologic, multicomponent intervention for LR. As such, the proposed research contributes much needed scientific knowledge toward identifying efficacious treatments for a highly prevalent, costly, and intractable condition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Participants will go through the multicomponent Move-MORE program. Move-MORE is an integrated mind-body intervention which combines mindfulness, physical activity, and motivational interviewing informed by the principles of self-determination theory
Move-MORE
Move-MORE is a multicomponent intervention which combines mindfulness training, physical activity, and motivational interviewing informed by the principles of self-determination theory. The version of Move-MORE being used in this study is specifically designed for use in patients with lumbosacral radiculopathy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Move-MORE
Move-MORE is a multicomponent intervention which combines mindfulness training, physical activity, and motivational interviewing informed by the principles of self-determination theory. The version of Move-MORE being used in this study is specifically designed for use in patients with lumbosacral radiculopathy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to stand for 10 minutes
* Presence of lumbosacral radicular pain within the past week that extends below the knee (i.e., pain radiating from the low back into the leg in a nerve root distribution) with or without accompanying low back pain, of at least 12 weeks' duration, AND
* Tampa Scale of Kinesiophobia score ≥ 23
* At least one positive physical examination finding consistent with lumbosacral radiculopathy, including at least one of the following:
* Positive straight leg raise test (eliciting radicular pain below the knee at ≤70 degrees of elevation);
* Positive Valsalva maneuver (eliciting radiculcar pain below the knee);
* Positive slump test;
* Neurological deficit in a lumbar nerve root distribution, including at least one of the following:
* Dermatomal sensory loss,
* Myotomal weakness, or
* Reduced or absent deep tendon reflexes (e.g., patellar or Achilles reflex) corresponding to the affected nerve root.
* Daily access to the internet via cell phone, tablet, or computer
* Willing to engage with Move-MORE 4-5 times per week on your own
* Willing to attend a two-hour-long virtual Zoom meeting once per week for eight weeks
* Willing to attend two in-person study visits and a follow-up visit
* Willing to complete 18 questionnaires pertaining to your pain symptoms, quality of life, psychosocial experiences, and your experiences in the trial
* Willing to wear an actigraphy device all day, every day, and while sleeping, for the duration of study participation and willing to keep it charged
* Willing to respond to a daily online survey for the duration of study participation
* Able to speak, read, and understand the English language
* Able to provide written informed consent
* Moderately motivated to participate as reported on a numeric rating scale (≥ 4/10)
Exclusion Criteria
* Participants with lumbosacral radiculopathy with progressive neurologic deficits will be referred for immediate medical attention, and are not eligible for participation in this study.
● Participants will be excluded if they have clinical signs or symptoms suggestive of cauda equina syndrome, including any of the following:
* New-onset urinary retention or overflow incontinence not attributable to other known causes;
* Fecal incontinence;
* New onset of saddle anesthesia (loss of sensation in the buttocks, perineum, and inner thighs);
* Severe or progressive bilateral lower extremity weakness;
* Participants with suspected cauda equina syndrome will be referred for immediate medical attention, and are not eligible for participation in this study.
* Presence of moderate to severe foot drop, defined as noticeable weakness in ankle dorsiflexion that interferes with walking or requires the use of an assistive device (e.g., ankle-foot orthosis). Participants with suspected or worsening foot drop will be referred for further evaluation and are not eligible for study participation.
* Current use of a spinal cord stimulator
* Have received epidural steroid injection in the prior 3 months
* Have received a surgical intervention for low back pain or lumbosacral radiculopathy in the previous 6 months
* Current active mindfulness meditation practice 1 time/week or more, and/or history of formal training in mindfulness/meditation practice
* Concurrent diagnosis of cancer
* Current unmanaged or uncontrolled mental illness known to cause psychosis: schizophrenia, schizotypal disorders, bipolar I disorder with psychosis, major depressive disorder with psychosis
* Diagnosis of Borderline Personality Disorder or score \>6 on the McLean Screening Instrument for Borderline Personality Disorder
* Initiation of or changes to an exercise regimen within 2 weeks prior to screening and/or enrollment
* Major medical or surgical event requiring hospitalization (for any reason other than a minor scheduled medical procedure) within 3 months prior to screening; or, scheduled or will be scheduled to occur within the 20 weeks (i.e., five months) after enrollment
* Currently participating in another interventional research study or participated in another interventional study within 2 weeks prior to screening
* Any reason the Clinical Investigator or Principal Investigator believes confers increased risk to the potential participant, if they were to enroll in the study
18 Years
66 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
National University of Natural Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ryan Wexler
Assistant Research Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University of Natural Medicine
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Study Coordinator, MA
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Helfgott Research Institute - Join a Study
Helfgott Research Institute - Projects
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RW6625
Identifier Type: -
Identifier Source: org_study_id